|
Getting your Trinity Audio player ready...
|
Synergy CHC Corp. (NASDAQ: SNYR), a leading provider of consumer health care and lifestyle products, has reported strong financial results for the first quarter ended March 31, 2025, marking its ninth consecutive quarter of profitability and signaling solid momentum for investors.
The company delivered 30% growth in earnings per share (EPS) year-over-year, reaching $0.10 per share compared to $0.08 in the same period last year. Net income jumped to $876.3 thousand, up from $580.5 thousand, while EBITDA rose to $1.98 million, reflecting enhanced operational efficiency. Gross margins also expanded significantly to 75.4%, up from 72.0%, and EBITDA margins surged to 24.1%, compared to 19.7% a year ago.
Revenue for the quarter came in at $8.2 million, compared to $9.4 million in Q1 2024. Despite the slight dip in revenue, Synergy’s disciplined cost management and robust brand performance sustained strong bottom-line growth.
CEO Jack Ross stated, “This performance highlights the strength of our operating model and our ongoing discipline around cost management.” Ross also emphasized strategic progress on key 2025 goals, including international expansion of FOCUSfactor and Ready-To-Drink beverages into three new markets, and broadening the Flat Tummy brand in response to increasing GLP-1 demand.
Synergy has also entered into term sheets to refinance existing debt, aiming to close the agreement soon. The expected refinancing will extend maturities to 2029 and improve near-term free cash flow, offering flexibility to pursue long-term growth strategies.
With strong financial momentum, expanding margins, product innovation, and a global growth roadmap, Synergy CHC Corp. is positioning itself as a compelling opportunity for growth-focused investors in the consumer wellness sector.